Karen Cárdenas-Martínez

Ms. Karen Cárdenas-Martínez

Universidad Nacional de Colombia - Sede Bogotá
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2021 in International Journal of Peptide Research and Therapeutics
Verified
Journal Article
Closed access
PDF file
KCKaren Cárdenas-Martínez
Karen Cárdenas-Martínez
DGDerly Grueso-Mariaca
Derly Grueso-Mariaca
Yerly Vargas-CasanovaYerly Vargas-Casanova
Yerly Vargas-Casanova
LBLaura Bonilla-Velásquez
Laura Bonilla-Velásquez
SESandra Mónica Estupiñán
Sandra Mónica Estupiñán
JCJavier Garcia Castañeda
Javier Garcia Castañeda

4 October 2023 in ACS Omega
Verified
Journal Article
Open access
KCKaren Cárdenas-Martínez
Karen Cárdenas-Martínez
ABAndrea C. Barragán-Cárdenas
Andrea C. Barragán-Cárdenas
MRManuela de la Rosa-Arbeláez
Manuela de la Rosa-Arbeláez
CPClaudia M. Parra-Giraldo
Claudia M. Parra-Giraldo
AOAlejandra Ochoa-Zarzosa
Alejandra Ochoa-Zarzosa
JCJavier Garcia Castañeda
Javier Garcia Castañeda
Anticancer peptides are increasingly being considered as alternative treatments for cancer due to their potency, selectivity, and low toxicity. Previously, the peptide LfcinB (21-25)Pal showed in vitro anticancer effects against the Caco-2 colon cancer cell line (half-maximal inhibitory concentration (IC50): 86 μM). In this study, we developed modifications to the peptide sequence to increase its anticancer activity. Sequence modifications were made such as the inclusion of amino hexanoic acid (Ahx), N-terminal biotinylation, acetylation, and substitutions of Orn for Arg and/or d-Arg by l-Arg. The molecules were synthesized using manual solid-phase peptide synthesis (SPPS), and their synthetic feasibility (SAScore) ranged from 6.2 to 7.6. The chromatographic purities of the synthesized peptides were greater than 89%. We found that Ahx-RWQWRWQWR and RWQWRWQW-Orn showed activity against both Caco-2 and HT-29 cell lines and decreased IC50 values by approx. 50% in Caco-2 cells (IC50: 40 μM) when compared to the parent peptide RWQWRWQWR. Moreover, the modified peptides demonstrated lower hemolytic effects, with values 100 mg/kg, indicating that their toxicity is classified as moderately toxic or lower. In contrast, cisplatin showed an LD50 of 13 mg/Kg. The designed anticancer peptides presented good in vitro activity and low toxicity, making them promising molecules for future drug development studies.

7 December 2020 in Current Organic Chemistry
Verified
Journal Article
Closed access
PDF file
AMAndrea Verónica Rodriguez Mayor
Andrea Verónica Rodriguez Mayor
GPGerman Jesid Peralta-Camacho
German Jesid Peralta-Camacho
KCKaren Cárdenas-Martínez
Karen Cárdenas-Martínez
JCJavier Garcia Castañeda
Javier Garcia Castañeda
Glycoproteins and glycopeptides are an interesting focus of research, because of their potential use as therapeutic agents, since they are related to carbohydrate-carbohydrate, carbohydrate-protein, and carbohydrate-lipid interactions, which are commonly involved in biological processes. It has been established that natural glycoconjugates could be an important source of templates for the design and development of molecules with therapeutic applications. However, isolating large quantities of glycoconjugates from biological sources with the required purity is extremely complex, because these molecules are found in heterogeneous environments and in very low concentrations. As an alternative for solving this problem, the chemical synthesis of glycoconjugates has been developed. In this context, several methods for the synthesis of glycopeptides in solution and/or solid phase have been reported. In most of these methods, glycosylated amino acid derivatives are used as building blocks for both solution and solid-phase synthesis. The synthetic viability of the glycoconjugates is a critical parameter for allowing their use as drugs to mitigate the impact of microbial resistance and/or cancer. However, the chemical synthesis of glycoconjugates is a challenge, because these molecules possess multiple reaction sites and have a very specific stereochemistry. Therefore, it is necessary to design and implement synthetic routes, which may involve various protection schemes but can be stereoselective, environmentally friendly, and high-yielding. This review focuses on glycopeptide synthesis by recapitulating the progress made over the last 15 years.

26 February 2025
Verified
Journal Article
Open access
PDF file
KCKaren Cárdenas-Martínez
Karen Cárdenas-Martínez
JRJuan Esteban Reyes-Calderón
Juan Esteban Reyes-Calderón
Claudia Marcela Marcela Parra-GiraldoClaudia Marcela Marcela Parra-Giraldo
Claudia Marcela Marcela Parra-Giraldo
Yerly Vargas-CasanovaYerly Vargas-Casanova
Yerly Vargas-Casanova
ACAndrea Barragán Cárdenas
Andrea Barragán Cárdenas
JCJavier Garcia Castañeda
Javier Garcia Castañeda
Aim: To identify peptides derived from bovine lactoferricin (LfcinB) as potential therapeutics for colon cancer treatment. We systematically modified dimeric peptides to enhance their selectivity against colon cancer cells and reduce toxicity. We examined the effects of specific changes, such as substituting L-arginine (Arg) with L-ornithine (Orn) and/or D-Arg, on cytotoxic activity in colon cancer cells, as well as activity in prostate and cervical cancer cell lines. Additionally, we assessed the type of cell death induced and the in vivo toxicity of the dimeric peptides. Methods: The peptides were synthesized by manual solid-phase peptide synthesis, purified by reverse phase-solid phase extraction (RP-SPE), and characterized by RP-high performance liquid chromatography (RP-HPLC), and mass spectrometry (MS). Their cytotoxic effect on cancer and non-cancerous cells was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The most promising dimeric peptide underwent scale-up synthesis to yield approximately 1 g. The type of induced cell death was analyzed through cytometry assays, while preliminarily toxicity studies were conducted in Galleria mellonella, zebrafish, and CD1 mice. Results: Our findings demonstrated that dimeric peptides containing L-Orn or D-Arg residues exhibited potent and selective cytotoxic effects against colon cancer cells (Caco-2 and HT-29), prostate cancer cells (DU-145), and cervical adenocarcinoma (HeLa). Notably, these modified peptides showed minimal toxicity in human erythrocytes, HEK 293 cells or fibroblasts, and Galleria mellonella larvae. Peptide 3: (R-Orn-WQWRFKKLG)2-K-Ahx, emerged as particularly promising, preserving its integrity and anticancer activity during scaled-up synthesis. Furthermore, peptide 3 induced behavioral changes and sedation in CD1 mice and showed significantly lower toxicity in zebrafish. Conclusions: The results suggested that specific modifications of Arg/Orn residues in dimeric peptides enhance their cytotoxicity against colon cancer cells and reduce in vivo toxicity. These modified peptides hold promise as safe and effective therapeutic candidates, potentially expanding the treatment options available for cancer.

23 July 2026 in Nature Communications
Verified
Journal Article
Open access
MDMandira Dutta
Mandira Dutta
KDKimberly A. Dolan
Kimberly A. Dolan
SASouad Amiar
Souad Amiar
EBElijah J. Bass
Elijah J. Bass
RSRokaia Sultana
Rokaia Sultana
RSRobert Stahelin
Robert Stahelin
M is the most abundant structural membrane protein in coronaviruses and is essential for the formation of infectious virus particles. SARS-CoV-2 M adopts two conformations, M short and M long , and regulated transition between states is hypothesized to coordinate viral assembly and budding. However, the factors that regulate M conformation and roles for each state are unknown. Here, we discover a direct M-sphingolipid interaction that controls M conformational dynamics, interaction with other structural proteins, and virus assembly. We show M binds Golgi-enriched anionic lipids including ceramide-1-phosphate (C1P). Molecular dynamics simulations show C1P interaction promotes a long to short transition and energetically stabilizes M short . Cryo-EM structures show C1P specifically binds M short at a conserved site bridging transmembrane and cytoplasmic regions. Disrupting M short -C1P interaction alters M subcellular localization, reduces colocalization with Spike and E, and reduces virus-like particle formation and cell entry. Together, these results show endogenous signaling lipids regulate M structure and support a model in which M short is stabilized in the early endomembrane system to organize other structural proteins prior to viral budding.